| Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies ML Sorror, BM Sandmaier, BE Storer, GN Franke, GG Laport, ... Jama 306 (17), 1874-1883, 2011 | 347 | 2011 |
| Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation R Storb, B Gyurkocza, BE Storer, ML Sorror, K Blume, D Niederwieser, ... Journal of Clinical Oncology 31 (12), 1530-1538, 2013 | 271 | 2013 |
| Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study … N Kröger, S Iacobelli, GN Franke, U Platzbecker, R Uddin, K Hübel, ... Journal of Clinical Oncology 35 (19), 2157-2164, 2017 | 260 | 2017 |
| Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or … DW Beelen, R Trenschel, M Stelljes, C Groth, T Masszi, P Reményi, ... The Lancet Haematology 7 (1), e28-e39, 2020 | 132 | 2020 |
| Monitoring of WT1 expression in PB and CD34+ donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced … T Lange, M Hubmann, R Burkhardt, GN Franke, M Cross, M Scholz, ... Leukemia 25 (3), 498-505, 2011 | 126 | 2011 |
| Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients M Bill, J Grimm, M Jentzsch, L Kloss, K Goldmann, J Schulz, S Beinicke, ... Annals of hematology 97 (10), 1757-1765, 2018 | 75 | 2018 |
| Comparison of real-time quantitative PCR and digital droplet PCR for BCR-ABL1 monitoring in patients with chronic myeloid leukemia GN Franke, J Maier, K Wildenberger, M Cross, FJ Giles, MC Müller, ... The Journal of Molecular Diagnostics 22 (1), 81-89, 2020 | 57 | 2020 |
| Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on … S Saussele, W Haverkamp, F Lang, S Koschmieder, A Kiani, ... Acta haematologica 143 (3), 217-231, 2020 | 45 | 2020 |
| Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation J Grimm, M Bill, M Jentzsch, S Beinicke, J Häntschel, K Goldmann, ... Bone Marrow Transplantation 54 (8), 1189-1197, 2019 | 42 | 2019 |
| Optimized digital droplet PCR for BCR-ABL J Maier, T Lange, M Cross, K Wildenberger, D Niederwieser, GN Franke The journal of molecular diagnostics 21 (1), 27-37, 2019 | 42 | 2019 |
| Prognostic impact of the CD34+/CD38− cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation M Jentzsch, M Bill, D Nicolet, S Leiblein, K Schubert, M Pless, ... American journal of hematology 92 (4), 388-396, 2017 | 40 | 2017 |
| Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation … JE Vaughn, ML Sorror, BE Storer, TR Chauncey, MA Pulsipher, ... Cancer 121 (20), 3709-3716, 2015 | 39 | 2015 |
| Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts B Gyurkocza, TM Cao, RF Storb, T Lange, W Leisenring, GN Franke, ... Biology of Blood and Marrow Transplantation 15 (10), 1314-1322, 2009 | 37 | 2009 |
| Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission M Jentzsch, L Bischof, D Backhaus, D Brauer, J Schulz, GN Franke, ... Blood Advances 6 (15), 4570-4580, 2022 | 35 | 2022 |
| Iron overload and its impact on outcome of patients with hematological diseases GN Franke, AS Kubasch, M Cross, V Vucinic, U Platzbecker Molecular Aspects of Medicine 75, 100868, 2020 | 31 | 2020 |
| Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades JP Cooper, BE Storer, N Granot, B Gyurkocza, ML Sorror, TR Chauncey, ... Haematologica 106 (6), 1599, 2021 | 30 | 2021 |
| Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity … C Pfrepper, A Klink, G Behre, T Schenk, GN Franke, M Jentzsch, ... Journal of cancer research and clinical oncology 142, 317-324, 2016 | 30 | 2016 |
| High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients M Jentzsch, M Bill, J Grimm, J Schulz, K Goldmann, S Beinicke, ... Oncotarget 8 (50), 87944, 2017 | 28 | 2017 |
| Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation M Jentzsch, L Bischof, J Ussmann, D Backhaus, D Brauer, KH Metzeler, ... Blood Cancer Journal 12 (12), 170, 2022 | 27 | 2022 |
| Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation M Bill, M Jentzsch, L Bischof, J Kohlschmidt, J Grimm, LK Schmalbrock, ... Blood Advances 7 (3), 436-444, 2023 | 24 | 2023 |
